Skip to main content
Log in

Benefit on motor and non-motor behavior in a specialized unit for Parkinson’s disease

  • Neurology and Preclinical Neurological Studies - Original Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

Treatment of patients with Parkinson’s disease in specialized units is quite common in Germany. Data on the benefit of this hospitalization of patients with Parkinson’s disease on motor and non-motor symptoms in conjunction with standardized tests are rare. Objective was to determine the efficacy of this therapeutic setting. We scored disease severity and performed clinical tests, respectively, instrumental procedures under standardized conditions in consecutively referred in-patients initially and at the end of their hospital stay. There was a decrease of motor and non-motor symptoms. The extent of improvement of non-motor and motor symptoms correlated to each other. Performance of complex movement sequences became better, whereas execution of simple movement series did not ameliorate. The interval for the timed up and go test went down. We demonstrate the effectiveness of an in-patient stay in a specialized unit for Parkinson’s disease. Objective standardized testing supplements subjective clinical scoring with established rating scales.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  • Berg D, Godau J, Seppi K, Behnke S, Liepelt-Scarfone I, Lerche S, Stockner H, Gaenslen A, Mahlknecht P, Huber H, Srulijes K, Klenk J, Fassbender K, Maetzler W, Poewe W (2013) The PRIPS study: screening battery for subjects at risk for Parkinson’s disease. Eur J Neurol 20:102–108

    Article  CAS  PubMed  Google Scholar 

  • Chaudhuri KR, Martinez-Martin P (2008) Quantitation of non-motor symptoms in Parkinson’s disease. Eur J Neurol 15(Suppl 2):2–7

    Article  PubMed  Google Scholar 

  • Chaudhuri KR, Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, Brown RG, Koller W, Barone P, Macphee G, Kelly L, Rabey M, Macmahon D, Thomas S, Ondo W, Rye D, Forbes A, Tluk S, Dhawan V, Bowron A, Williams AJ, Olanow CW (2006) International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 21:916–923

    Article  PubMed  Google Scholar 

  • Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, Ondo W, Abe K, Macphee G, Macmahon D, Barone P, Rabey M, Forbes A, Breen K, Tluk S, Naidu Y, Olanow W, Williams AJ, Thomas S, Rye D, Tsuboi Y, Hand A, Schapira AH (2007) The metric properties of a novel non-motor symptoms scale for Parkinson’s disease: results from an international pilot study. Mov Disord 22:1901–1911

    Article  PubMed  Google Scholar 

  • Fahn S, Elton R, Members of the UPDRS Development Committee (1987) Unified Parkinson’s Disease Rating Scale. Macmillan, New York, pp 153–163

    Google Scholar 

  • Maetzler W, Kruger R, Müller T, Oertel W, Urban P, Warnecke T, Klucken J (2016) Wearable technique for the assessment of parkinson symptoms: what’s the future? Fortschr Neurol Psychiatr 84(Suppl 1):S48–S51

    PubMed  Google Scholar 

  • Müller T (2014) Tolcapone addition improves Parkinson’s disease associated nonmotor symptoms. Ther Adv Neurol Disord 7:77–82

    Article  PubMed  PubMed Central  Google Scholar 

  • Müller T, Woitalla D (2010) Quality of life, caregiver burden and insurance in patients with Parkinson’s disease in Germany. Eur J Neurol 17:1365–1369

    Article  PubMed  Google Scholar 

  • Müller T, Schafer S, Kuhn W, Przuntek H (2000) Correlation between tapping and inserting of pegs in Parkinson’s disease. Can J Neurol Sci 27:311–315

    Article  PubMed  Google Scholar 

  • Müller T, Voss B, Hellwig K, Josef SF, Schulte T, Przuntek H (2004) Treatment benefit and daily drug costs associated with treating Parkinson’s disease in a Parkinson’s disease clinic. CNS Drugs 18:105–111

    Article  PubMed  Google Scholar 

  • Siderowf AD, Werner RM (2001) The EQ-5D—a generic quality of life measure—is a useful instrument to measure quality of life in patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 70:817

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zampieri C, Salarian A, Carlson-Kuhta P, Aminian K, Nutt JG, Horak FB (2010) The instrumented timed up and go test: potential outcome measure for disease modifying therapies in Parkinson’s disease. J Neurol Neurosurg Psychiatry 81:171–176

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Müller.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Müller, T., Öhm, G., Eilert, K. et al. Benefit on motor and non-motor behavior in a specialized unit for Parkinson’s disease. J Neural Transm 124, 715–720 (2017). https://doi.org/10.1007/s00702-017-1701-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-017-1701-3

Keywords

Navigation